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The link between childhood trauma and dissociation in frequent users of classic
psychedelics and dissociatives
Sascha B. Thala, Judith K. Danielsa,b, and Henrik Jungaberle c,*
aDepartment of Clinical Psychology, Faculty of Behavioural and Social Sciences, University of Groningen, Groningen, Netherlands; bPsychological
University Berlin, Berlin, Germany; cFINDER Institute for Prevention Research, Berlin, Germany
ABSTRACT
Background: Childhood trauma severity is associated with the level of subsequent substance use as well as
with the self-reported severity of dissociation. Classic psychedelics and dissociatives target neurotrans-
mitter systems thought to be involved in the onset of dissociative symptoms and may evoke severe and
long-lasting symptoms of depersonalization in some users. However, it is currently unclear whether drug
use puts people with a history of childhood trauma at higher risk of developing dissociative symptoms.
Objectives: The current study investigates whether the one-year prevalence of substance use signifi-
cantly moderates the link between childhood trauma and the severity of depersonalization.
Methods: Participants (n = 297, of which 80.2% were active users) filled out an online self-report
questionnaire including the Childhood Trauma Questionnaire (CTQ), the Cambridge Depersonalisation
Scale (CDS), and information about their substance use.
Results: Results indicate that childhood trauma and substance use are significant individual predictors of
dissociation scores in this sample, but no moderation of substance use on the link between childhood
trauma and depersonalization was established.
Conclusions: It is hypothesized that the quality (particularly the context) of the experience of substance
use rather than the sheer quantity may be responsible for the manifestation of depersonalization.
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It is well established that the severity of childhood trauma is
associated both with levels of substance use and the severity of
dissociation (Diseth, 2005; Najavits & Walsh, 2012; Najavits,
Weiss, & Shaw, 1997). Three times higher rates of substance
abuse in subjects with vs. without a history of childhood
trauma have been reported in the general population
(Kilpatrick, Saunders, & Smith, 2003), and the severity of
childhood trauma is closely linked to the level of substance
abuse (Khoury, Tang, Bradley, Cubells, & Ressler, 2010;
Scheidell et al., 2018). In addition, subjects with childhood
trauma were 1.5 times more likely to report illicit substance
use within the past year (Widom, Marmorstein, & White,
2006). However, whether the level of substance use can partly
explain the relationship between trauma severity and the
severity of subsequent dissociation is currently unknown.
Link between childhood trauma, dissociation, and
substance use
Dissociation is defined as a disruption of the normal integration of
a person’s conscious and psychological functions and as such can
potentially disrupt every area of mental functioning (DSM-5).
Most experiences of dissociation entail symptoms of depersonali-
zation, which refers to self-related alterations including emotion
processing, perception, and body experience. Dissociation in the
form of depersonalization correlates significantly with the levels of
reported childhood trauma (Michal et al., 2007; Simeon, Guralnik,
Schmeidler, Sirof, & Knutelska, 2001). However, the causal rela-
tionships underlying this association have been widely debated
(see Dalenberg et al., 2012; Lynn et al., 2014). Some authors have
suggested that additional moderators might have to be taken into
account, suggesting a multifactorial model of dissociation (Lynn
et al., 2014).
The link between childhood trauma, substance use, and dis-
sociative experiences as well as high prevalence rates of comorbid
substance use disorders in patients suffering from dissociative
disorders (e.g., Dunn, Ryan, Paolo, & Van Fleet, 1995; Karadag
et al., 2005) are well-established (Najavits & Walsh, 2012; Schäfer
et al., 2010; Van Den Bosch, Verheul, Langeland, & Van Den
Brink, 2003). While several psychoactive substances are known to
have dissociative properties, others (like benzodiazepines or aty-
pical antipsychotics) might specifically attract users suffering from
dissociative experiences due to their anti-dissociative properties.
Neurotransmitter systems that are thought to play a role in
depersonalization include N-methyl-D-aspartate (NMDA),
opium, and serotonin receptors (Simeon, 2004).
Classic psychedelics
Classic psychedelics or hallucinogens (including – among
others – psilocybin, LSD, mescaline, and DMT or ayahuasca)
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are a class of psychoactive substances that trigger distinct
forms of altered states of consciousness. They are character-
ized by their high affinity for serotonin receptors (Ray, 2010),
but they also act on the glutamate and dopamine system
(Vollenweider & Preller, 2016). Lifetime prevalence in the
US of LSD, psilocybin, and mescaline use in people aged 21
to 64 was estimated to be 17% (Krebs & Johansen, 2013a).
Classic psychedelics may induce a continuum of feelings ran-
ging from happiness and oceanic boundlessness to anxiety,
panic, paranoia, and psychosis (Nichols, 2016). They acutely
alter visual perception and perception of time, self-experience,
mood, thoughts, attention, working-memory, and suggestibil-
ity (Carhart-Harris et al., 2015; Hasler, Grimberg, Benz,
Huber, & Vollenweider, 2004; Nichols, 2016; Studerus,
Kometer, Hasler, & Vollenweider, 2011). Even though popu-
lation studies indicate that the recreational use of classic
psychedelics is not associated with an increased risk for the
emergence of psychiatric disorders (Hendricks, Thorne, Clark,
Coombs, & Johnson, 2015; Johansen & Krebs, 2015), severe
and long-lasting symptoms can be evoked in some users.
Dissociatives
The term “dissociatives” comprises substances which primar-
ily act as NDMA receptor antagonists and may operate as
agonists for various opium receptors. The most known dis-
sociatives are Phencyclidine (PCP), Ketamine, and
Dextromethorphan (DXM).
The effects of dissociatives often include sedation, distor-
tion of perception, euphoria, confusion, cognitive impair-
ment, and dissociative symptoms (Berman et al., 2000;
Betzler & Majić, 2017; Murrough et al., 2013; Zarate et al.,
2006). High doses may elicit strong symptoms of depersona-
lization including a complete loss of the self-experience, hal-
lucinations, flashbacks, perceptual changes in all sensory
modalities, and out-of-body experiences (Curran & Morgan,
2000; Jansen, 1989, 2011; Morgan & Curran, 2012; Morgan,
Monaghan, & Curran, 2004; Muetzelfeldt et al., 2008).
In 2014, lifetime prevalence usage of PCP and Ketamine in
US high-school seniors was around 2% (UNODC, 2014).
Substance use as a coping strategy to deal with
trauma and dissociation?
Dissociative symptoms often start in adolescence, preceding
the substance use in the majority of the cases (Karadag et al.,
2005). Substance use typically commences in late adolescence
or early adult life, at times as a form of self-medication to
counteract trauma-related symptoms emerging from dysregu-
lated biological stress responses (Najavits, 2002; Roesler &
Dafler, 1993) whereby those with more severe symptoms of
dissociation express stronger expectations to manage their
symptoms using substances (Najavits & Walsh, 2012).
However, classic psychedelics and dissociatives target neuro-
transmitter systems thought to be implicated in the onset of
dissociative symptoms such as glutamateNMDA receptor antago-
nists, serotonin receptor agonists, and opioid receptor agonists
(see Simeon, 2004) and may evoke acute and in some users also
long-term effects that resemble the qualitative experience of
depersonalization. Short-term dissociative effects of psychedelics
have long been established (Denson, 1967; Kenna & Sedman,
1964) and are thought to closely resemble clinical effects of dis-
sociation (Luckenbaugh et al., 2014; Morgan, Riccelli, Maitland, &
Curran, 2004). However, illicit drug use (most commonly canna-
bis and hallucinogens) can also trigger chronic depersonalization
(Simeon, Kozin, et al., 2009). It is currently unknown whether
repetitive experiences (i.e., the quantity) of substance-induced
depersonalization do more often cause severe or long-lasting
depersonalization in subjects prone to dissociation due to their
history of childhood trauma.
Goal for the current study
While it is known that the severity of childhood trauma is
associated with the severity of subsequent dissociation, it is
unclear whether the intervening usage of illicit drugs might
partially explain this relationship, i.e., whether the severity of
the experienced trauma predicts the severity of subsequent
dissociative symptoms better when illicit drugs have amplified
dissociative tendencies, i.e., when the diathesis induced by
childhood trauma is actualized by the drug use.
The question thus arises whether the use of classic psyche-
delics and dissociatives might moderate the relationship
between childhood trauma severity and the reported deperso-
nalization levels, i.e., whether the positive relationship
between childhood trauma and depersonalization is stronger
for higher rates of substance use.
Method
Participants
Participants were recruited using social media pages and groups
relevant to substance use and harm reduction content in order to
include frequent users of specific classes of substances. Of 1007
participants who started filling out the questionnaire, n = 703
participants were excluded due to large amounts of missing data.
Arbitrary responses were omitted, and subjects indicating a one-
year prevalence of use of classic psychedelics and dissociatives on
more than 100 occasions were checked individually leading to the
exclusion ofn=4 cases. Furthermore, participants under the age of
16 (n = 3) were excluded from the analysis. After the exclusion
procedure, n = 297 participants (44 (14.8%) women, 245 (82.5%)
men, and 8 (2.7%) who identified as other sexes) ranging in ages
from 16 to 63 (M= 23.71, SD= 8.10) were included in the analysis.
Only n = 61 (12 women, 48 men, and 1 who identified as another
sex) ranging in ages from 17 to 47 (M = 22.08; SD = 6.51)
subsequently excluded subjects provided sociodemographic data,
which indicated no significant differences in age (t (356) = 1.48,
two-tailed p= .14) or sex (χ2(2) = 1.08, p= .58) between these drop-
outs and the participants.
Materials
Childhood trauma
For assessing childhood trauma, the 28-item self-report
Childhood Trauma Questionnaire (CTQ; Bernstein & Fink,
1998; sample Cronbach α = .805) was used. Participants had
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to indicate on a 5-point Likert scale ranging from 1 “Never
true” to 5 “Very often true” to what extent they agreed with
statements concerning their childhood. Sub-scale sum scores
for emotional abuse, physical abuse, sexual abuse, emotional
neglect, and physical abuse were computed and a total CTQ
sum score was calculated by summing these.
Depersonalization severity
Symptom severity of depersonalization was assessed using the
29-item self-report Cambridge Depersonalisation Scale (CDS;
Sierra & Berrios, 2000; sample Cronbach α = .965).
Participants rated the frequency and duration of dissociative
experiences on a 5-point Likert scale ranging from 0 “Never”
to 4 “All the time” and on a 6-points Likert scale ranging from
1 “Few seconds” to 6 “More than a week”, respectively. An
additional question regarding the age of onset of dissociative
symptoms was included. Frequency and duration items for
the CDS were added up separately in order to arrive at dis-
crete sum scores for frequency and duration. For the overall
CDS sum score used in the model, all frequency and duration
items were summed up.
Substance use
Demographic data (i.e., age, sex) and patterns of substance use
were measured by a shortened and adapted version of
a questionnaire constructed and utilized by the European
School Survey Project on Alcohol and Other Drugs (ESPAD).
Questions regarding prevalence of alcohol use, tobacco use,
and cannabis use were answered in an open format, while
questions concerning the lifetime and yearly prevalence of the
use of classic psychedelics, dissociatives, and other psychoac-
tive substances were answered on a scale ranging from 0 to
1000. Further, questions about the prevalence of the use of
classic psychedelics and dissociatives during the last 30 days
were answered on a scale ranging from 0 to 100. We further
followed the approach by Morris and Wallach (2014) and
focused on uncompetitive NMDA-receptor antagonists and
their analogues and thus excluded selective kappa opioid
receptor (KOR) agonists like Salvinorin A, as it may not be
regarded as dissociative in the narrow sense due to its specific
psychoactive and pharmacodynamic features (see Betzler and
Majić, 2017; Johnson, MacLean, Reissig, Prisinzano, &
Griffiths, 2011). Mixed NMDA-receptor antagonist/KOR ago-
nists and classic psychedelics with minor epidemiological
relevance (see Sumnall, 2018) were excluded as well. The
questions assessing the age of first-time substance listed ages
9 to 25 as well as the option “older than 25”.
One-year prevalence of classic psychedelics was computed by
adding up the number of occasions Ayahuasca, LSD, mescaline,
DMT, and psilocybin were used in the past year. One-year
prevalence for dissociatives was calculated by adding up the
number of occasions Ketamine, PCP, DXM, 2-
Fluorodeschloroketamine, Eticyclidone, 3-Methoxyeticyclidine,
3-, 4-Methoxyphencyclidine, Deschloroketamine, Ephenidine,
Methoxetamine, and Methoxphenidine were used in the
past year, and the three items indicating consumption of addi-
tional dissociative substances. Eventually, the one-year
prevalence of use of both substances was calculated by adding
up their sum scores of one-year prevalences.
Procedure
Ethics for the study was granted by the Ethical Committee of
Psychology of the University of Groningen in December 2017.
Data collection took place between December 2017 and
February 2018. Harm reduction and substance information
centers, associations, and websites like PsychonautWiki (psy-
chonautwiki.org), Eve&Rave (eve-rave.ch), Chill out e. V., and
MIND European Foundation for Psychedelic Science (MIND
Foundation) supported the distribution of the link to the
online questionnaire on Qualtrics through various channels.
The survey was estimated to take 20 min to be filled out.
Participation was voluntary and anonymous; participants
were given one week to complete the questionnaires and it
was made clear to them that they may withdraw their coop-
eration at any time. Due to the nature of some questions, they
were further informed about the possibility of experiencing
distress. International websites with trauma-related informa-
tion were therefore provided in the debriefing. They were not
offered any compensation for their participation and provided
written informed consent before study participation.
Data analysis
The data were analyzed using SPSS version 25. Only complete
data sets were considered for the analysis. As stated in the
pre-registration (https://aspredicted.org/see_one.php?a_id=
7496), scores on the extreme ends of the scales for trauma
exposure and dissociation severity, i.e., potential outliers, were
not excluded as they might indeed be valid cases.
The criterion and the predictor variables were standardized
(Aiken, West, & Reno, 1991) following graphical inspection of
the residuals. A multiple regression analysis (Baron & Kenny,
1986) with one-year prevalence of substance use and childhood
trauma severity as predictors was computed. Moderation was
tested by regressing the dependent variable CDS on childhood
trauma severity and on one-year prevalence of substance use as
well as the interaction of the two. Ad hoc, explorative analyses
were run by including lifetime prevalence and one-month pre-
valence of use separately as predictors into the model. The sum
scores of use of classic psychedelics and dissociatives were also
separately included into the analysis. The statistical threshold
for significance testing was set to p ≤ .05 (two-sided).
Results
In the sample, 72.7% of participants used classic psychedelics
at least once during the past year, mostly LSD (58.9%) and
psilocybin (44.4%; see Table 1 for details). In addition, 45.8%
of the participants consumed dissociatives at least once during
the past year (mostly Ketamine (22.2%) and DXM (20.2%)).
Overall, 80.2% of participants used either classic psychedelics
or dissociatives during the past year. On average, participants
reported using these substances 20.46 times during the
last year (SD = 51.42, Range = 0 to 506).
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The sample was characterized by elevated levels of deper-
sonalization (CDS, M = 51.11; SD = 43.45) and childhood
trauma (CTQ, M = 43.44; SD = 13.66) which is discussed
below.
All three variables correlated significantly with each other,
with CTQ scores and CDS scores showing the highest corre-
lation (r = .37, p < .001), while substance use frequency
correlated with r = .15 (p = .005) with CTQ scores and with
r = .18 (p = .001) with CDS.
In the regression analysis, CDS scores were significantly
predicted (R Square = .200; F (1, 291) = 18.31; p < .001)
through CTQ (Beta = .388), substance use (Beta = .108) scores
as well as age (Beta = − .219), while sex was not a significant
predictor (see Table 2). However, inclusion of the interaction
term did not result in a significant increase (R Square = .204;
F (1, 291) = 1.32, p = .25), i.e., indicating that there was no
moderation effect.
Subsequently, the analysis was repeated using lifetime pre-
valence and one-month prevalence of use of classic psyche-
delics and dissociatives as moderator variables. No significant
interaction terms were found there, either (lifetime prevalence
F (1, 291) = 0.27, p = .60; one-month prevalence F (1, 291) =
2.37, p = .13).
To test for differential associations of the two substance
classes, one-year prevalence of classic psychedelics (t = 1.77,
p = .08) and dissociatives (t = 1.52, p = .13) were taken into
account separately. Again, no significant interactions were
found for either class of substances (classic psychedelics
F (1, 291) = 1.85, p = .18; dissociatives F (1, 291) = 1.66, p=
.20). When regressing CDS frequency- and duration scores
separately on CTQ and on one-year prevalence of substance
use and the interaction of the two, no significant interaction
effect was found in either model (frequency F (1, 291) = 0.63,
p = .43; duration F (1, 293) = 1.83, p = .18).
Discussion
The current study reconfirmed that dissociation severity in
the form of depersonalization is predicted by both the severity
of childhood trauma and the usage of illicit substances (i.e.,
classic psychedelics and dissociatives) over the last year.
However, the data indicate that the link between traumatic
childhood experiences and dissociative phenomena is not
moderated by the quantity of classic psychedelics and
dissociatives used by the participants. The association between
the severity of childhood trauma and depersonalization is thus
not contingent upon drug usage, as a diathesis-stress model
might have predicted.
In addition, childhood trauma explained much more var-
iance in dissociation severity (13.8%) than substance use
(1.2%). And while age explained an additional 5% of variance,
the lion share of the variance was not attributable to one of
the tested predictors. When classic psychedelics and dissocia-
tives were separately included into the model, both were
rendered non-significant suggesting that cumulative effects
of several substances (i.e., polydrug use) may play a role in
depersonalization – or that common underlying factors in
polydrug use (e.g., individual (epi)genetics or sensation-
seeking) may have to be investigated further.
Sample characteristics
Average childhood trauma severity in the current sample was
comparable to those reported in subjects with an alcohol
addiction (Schäfer et al., 2010), but higher than in subjects
without any psychiatric diagnoses (Simeon, Giesbrecht, et al.
2009). Additionally, participants in the present sample scored
well below the determined threshold for clinical levels of
depersonalization (Sierra & Berrios, 2000) and lower than
a sample of DPD patients (Simeon, Giesbrecht et al. 2009),
but exhibited higher CDS scores than subjects diagnosed with
PTSD and healthy controls (Simeon, Giesbrecht et al. 2009).
That the current sample reported higher depersonalization
values than PTSD patients on average is somewhat surprising
and might be due to the fact that their substance use by far
exceeds levels represented in the general population (see, e.g.,
Pfeiffer-Gerschel, Jakob, & Stumpf, 2014; UNODC, 2014).
Limitations and recommendations for future studies
The generalizability of the results is limited by potential biases
of convenience samples (see Bornstein, Jager, & Putnick,
2013). As a result, subjects with limited access to the internet,
limited power of concentration, or those severely impaired
due to clinical psychopathology may be underrepresented in
the study. As high-frequency substance users were targeted,
reported rates of substance use may exceed the average usage
in traumatized people and thus should not be generalized to
all traumatized populations. Women are underrepresented in
this study as compared to the general population, which is
due to the fact that users of substance use and harm-reduction
websites are known to be predominantly males in their twen-
ties with high consumption rates of illicit substances (Baggott,
Erowid, Erowid, Galloway, & Mendelson, 2010; Chiauzzi,
Dasmahapatra, Lobo, & Barratt, 2013; Orsolini, Papanti,
Francesconi, & Schifano, 2015; Temple & Brown, 2011).
Future studies should, therefore, test specifically whether the
experience of depersonalization is differentially influenced by
substance use in women.
We did not collect data on the use of selective KOR
agonists and mixed NMDA-receptor antagonist/KOR ago-
nists. As these substances exhibit dissociative properties but
were not included in the current study, their association with
Table 2. Regression of depersonalization severity as measured with the
Cambridge Depersonalisation Scale on sex, age, childhood trauma severity as
measured with the Childhood Trauma Questionnaire (CTQ) and substance use
(N = 297).
Model B Std. Error Beta t Sig. (p)
1 (Constant) .135 .083 1.625 .105
Sex −.026 .142 −.010 −.183 .855
Age −.223 .054 −.219 −4.108 <.001
CTQ .400 .056 .388 7.189 <.001
Substance Use 1.389 .683 .108 2.035 .043
2 (Constant) .174 .090 1.941 .053
Sex −.038 .143 −.014 −.269 .788
Age −.226 .054 −.222 −4.164 <.001
CTQ .382 .058 .370 6.595 <.001
Substance Use 1.759 .754 .137 2.331 .020
Substance Use x CTQ −.383 .334 −.068 −1.148 .252
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childhood trauma could not be tested. Future studies should
aim to recruit a sample large enough to warrant such an
analysis.
The current study only tested the influence of the amount
of drug use, not taking the quality of the experience
(Roseman, Nutt, & Carhart-Harris, 2018) and context of
usage (Carhart-Harris et al., 2018) into account. It is concei-
vable that the context substances are used in may influence
the outcome resulting in certain people experiencing deper-
sonalization after using aforementioned substances on a single
occasion whereas other people may use them multiple times
without negative ramifications (see Krebs & Johansen, 2013b;
Simeon, Kozin, et al. 2009). In addition, the reported deper-
sonalization could also have been the result of withdrawal
from other substances (Djenderedjian & Tashjian, 1982;
Shufman, Lerner, & Witztum, 2005) and pharmaceuticals
(Ashton, 1991; Marriott & Tyrer, 1993; Mourad, Lejoyeux,
& Adès, 1998; Terao, Yoshimura, Terao, & Abe, 1992).
Additional factors potentially influencing the relationship
between retrospectively reported childhood trauma and deper-
sonalization severity, such as level of education (Michal et al.,
2015), polydrug use, prescription medications (Ashton, 1991;
Marriott & Tyrer, 1993; Mourad et al., 1998; Terao et al., 1992),
suggestibility (Giesbrecht, Lynn, Lilienfeld, & Merckelbach,
2008), and specific psychiatric diagnoses (Baker et al., 2003;
Simeon, Knutelska, Nelson, & Guralnik, 2003) might have influ-
enced the results and should be controlled for in future studies.
Finally, it has to be stressed that the findings are merely
based on cross-sectional correlations and cannot conclusively
demonstrate whether the reported trauma experiences and
substance use preceded depersonalization (see Aldrich, 1995).
Conclusion and outlook
Childhood trauma and substance use were established as
significant independent predictors of depersonalization
scores. However, results did not indicate a moderation effect
for substance use on the link between childhood trauma and
depersonalization. The results of the present study are impor-
tant in that they replicate past findings regarding traumatic
childhood experiences and their positive association with
facets of dissociation (e.g., Diseth, 2005; Simeon et al., 2001).
These findings should be used in substance use prevention.
However, more research regarding the quality of the experi-
ence as well as other possible moderator variables are needed
in order to shed light on how traumatic childhood experi-
ences translate to depersonalization.
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